Blog Archives

Risiko einer Hepatitis-B-Reaktivierung unter Therapie mit BCR-ABL Tyrosinkinaseinhibitoren

10. April 2016 – In Deutschland informieren die Firmen Novartis, Bristol-Myers Squibb, Pfizer, und ARIAD Pharmaceuticals mittels eines Rote-Hand-Briefes über das Risiko einer Hepatitis B Virus-Reaktivierung nach Anwendung von BCR-ABL Tyrosinkinaseinhibitoren und die Notwendigkeit der Untersuchung von Patienten auf Hepatitis B Viren vor Behandlungsbeginn. Bei Patienten,

Read more ›

Tags: , , , , , , , , , , ,

Die Anwendung von Viekirax mit Exviera bei Child-Pugh-B und Child-Pugh-C Patienten kann zu fatalem Leberversagen führen

09. April 2016 – Gemäss einer sogenannten DHPC (Health Professional Communication) vom 8. April 2016 orientiert Swissmedic zusammen mit der Inhaberin der Zulassungsbewilligung (AbbVie) über ernsthafte und teilweise fatale Nebenwirkungen in einer Gruppe von Patientinnen / Patienten nach Hepatitis C CirrhosisBehandlung chronischer Hepatitis C  (CHC) mit Viekirax,

Read more ›

Tags: , , , , , , , , , , ,

Schwere Leberschädigungen, welche mit der Anwendung von Dronedaron [Multaq] in Verbindung gebracht werden.

21. Januar 2011 – In Abstimmung mit dem Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) informiert die Firma Sanofi-Aventis über schwerwiegende Leberschädigungen, die mit der Anwendung von Dronedaron [Multaq] aufgetreten sind, sowie über notwendige Kontrolluntersuchungen.

1. Es sind Fälle von Leberschädigung bei Patienten, die mit Dronedaron [Multaq] behandelt wurden,

Read more ›

Tags: , , , , , , , ,

thasso: zustände

thasso: kurzmitteilungen

thasso post: magazin

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Study examines genetic testing in diverse young breast cancer patients over a decade January 28, 2020
    Breast cancer patients diagnosed under age 50 represent 18 percent of new invasive breast cancer cases in the United States. Compared to postmenopausal women, younger women are more likely to develop aggressive subtypes of breast cancer, have a worse prognosis with increased risk of recurrence, and have higher overall mortality. Young breast cancer patients also […]
  • Novel insight into chromosome 21 and its effect on Down syndrome January 28, 2020
    A UCL-led research team has, for the first time, identified specific regions of chromosome 21, which cause memory and decision-making problems in mice with Down syndrome, a finding that provides valuable new insight into the condition in humans.
  • Decoding sickle cell disease January 28, 2020
    When Lamarcus Jean visits the Hematology Clinic at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, he makes himself right at home. The 6-year-old, whom his mom, Stephanie, describes as "wise beyond his years," has been a patient here since he was born.
  • Gender differences in autism January 28, 2020
    Tools used for screening autism may play a part in the failure to detect autism in girls and women, researchers at Bournemouth University have found.
  • New gene correction therapy for Duchenne muscular dystrophy January 28, 2020
    Duchenne type muscular dystrophy (DMD) is the most common hereditary muscular disease among children, leaving them wheelchair-bound before the age of 12 and reducing life expectancy. Researchers at Technical University of Munich (TUM), Ludwig Maximilian University of Munich (LMU) and the German Research Center for Environmental Health (Helmholtz Zentrum München) have developed a gene therapy […]
Top